13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
Live feed/ Filings/ SCHEDULE 13G/ 0001346824-26-000195
SCHEDULE 13G Filed 2026-07-20 Event — SEC 0001346824-26-000195 →

RA CAPITAL MANAGEMENT, L.P. → Agenus Inc. AGEN

Stake: — Shares: — Class: Common Stock, $0.01 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
2 13D/G filings on this issuer
1 other filing besides this one
Filer Track Record
76 filings by this filer
75 other filings in the data moat
Short Interest · settle 2026-06-30
DTC 5.42
5,994,778 shares short · +25.5% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $340K
Point72 Asset Mgmt

Other 13D/G Filings on Agenus Inc.

FiledFormFilerStakeShares
2026-07-17 SCHEDULE 13G Invus Global Management, LLC — — view →

Other Filings by RA CAPITAL MANAGEMENT, L.P.

FiledFormIssuerStakeShares
2026-07-21 SCHEDULE 13D/A VOR BIOPHARMA INC. — 12,937,855 view →
2026-07-07 SCHEDULE 13D/A Climb Bio, Inc. CLYM 33.00% 23,249,186 view →
2026-07-02 SCHEDULE 13D/A WEREWOLF THERAPEUTICS, INC. HOWL 4.10% 1,985,541 view →
2026-06-26 SCHEDULE 13D/A WEREWOLF THERAPEUTICS, INC. HOWL 6.00% 2,915,742 view →
2026-06-24 SCHEDULE 13D/A SOLID BIOSCIENCES INC. SLDB — 12,036,126 view →
2026-06-22 SCHEDULE 13D/A WEREWOLF THERAPEUTICS, INC. HOWL — 3,654,307 view →
2026-06-18 SCHEDULE 13D Parabilis Medicines, Inc. PBLS 23.80% 28,933,371 view →
2026-06-15 SCHEDULE 13D/A ARTIVA BIOTHERAPEUTICS, INC. ARTV 36.60% 17,811,623 view →
2026-06-15 SCHEDULE 13D/A WEREWOLF THERAPEUTICS, INC. HOWL — 5,138,703 view →
2026-06-03 SCHEDULE 13G Editas Medicine, Inc. EDIT — — view →
2026-05-21 SCHEDULE 13G Sana Biotechnology, Inc. SANA — — view →
2026-05-14 SCHEDULE 13D/A WEREWOLF THERAPEUTICS, INC. HOWL — 6,116,140 view →
2026-05-13 SCHEDULE 13D/A ARTIVA BIOTHERAPEUTICS, INC. ARTV — 16,377,468 view →
2026-01-09 SCHEDULE Cidara Therapeutics, Inc. — — view →
2025-11-07 SCHEDULE LENZ Therapeutics, Inc. LENZ 13.60% 4,265,106 view →
2025-11-07 SCHEDULE Sionna Therapeutics, Inc. SION 22.60% 10,071,712 view →
2025-11-03 SCHEDULE 89bio, Inc. — — view →
2025-10-01 SCHEDULE ARS Pharmaceuticals, Inc. SPRY 11.10% 10,940,977 view →
2025-09-30 SCHEDULE PepGen Inc. PEPG 29.20% 20,099,753 view →
2025-08-11 SCHEDULE Cidara Therapeutics, Inc. 13.30% 3,365,523 view →
Showing 20 of 75

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →